Human medicines European public assessment report (EPAR): Xadago, safinamide, Parkinson Disease, Date of authorisation: 23/02/2015, Revision: 9, Status: Authorised

2019 ◽  
Author(s):  
Sign in / Sign up

Export Citation Format

Share Document